US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monkeypox Concept

1,399.83

-4.1056-0.29%

Number of Gainers:2

Number of Losers:9

Number of Flat:- -

PE:- -

High:1,409.65

Open:1,403.41

Low:1,384.46

Close:1,403.94

Loading ...

2 Top Dividend Stocks That Could Set You Up for Life

Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule

MT Newswires Live

Siga Technologies Shares Climb on Special Dividend

SIGA Technologies Declares Special Cash Dividend of $0.60 per Share, Payable May 15 to Holders as of April 29

MT Newswires Live

Gilead Sciences: The Global Health Challenge of HIV and Hepatitis B Coinfections

ACCESS Newswire

Applied DNA regains compliance with Nasdaq minimum bid price rule

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

ACCESS Newswire

SIGA Declares Special Cash Dividend of $0.60 per Share

THOMSON REUTERS

Press Release: SIGA Declares Special Cash Dividend of $0.60 Per Share

Siga Technologies Inc. (SIGA) Declines More Than Market: Some Information for Investors

5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025

Viatris to Pay Up to $335M in Opioid Settlement

Viatris Shares Down 4.7% as Co to Pay up to $335 Million to Resolve Opioid-Related Claims

THOMSON REUTERS

Wall Street Sinks Into Tariff Turmoil as US Equity Futures Drop Pre-Bell

MT Newswires Live

BUZZ-Viatris resolves opioid-related claims for $335 mln; shares rise

Viatris to pay up to $335 million to resolve opioid-related claims

Viatris to Settle Opioid Claims Through Nationwide Framework

MT Newswires Live

Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects

Viatris reaches nationwide settlement to resolve opioid-related claims

BRIEF-Viatris Statement On Nationwide Settlement To Resolve Opioid-Related Claims

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4583/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1399.831,"timestamp":1745265599999,"preClose":1403.9366,"halted":0,"volume":21362641,"delay":0,"changeRate":-0.002924,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-4.105591,"latestTime":"04-21 16:00:00 EDT","open":1403.4071,"high":1409.6544,"low":1384.4579,"amount":1018064589.820761,"amplitude":0.017947,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.467434,"peRate":530.699707,"turnoverRate":0.007862,"increases":2,"decrements":9,"flats":0,"marketCap":157928380119.5,"floatMarketCap":157302737571.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1409.6544,"amplitude":0.017947,"preClose":1403.9366,"low":1384.4579,"pbRate":"3.467434","latestPrice":1399.831,"volume":21362641,"delay":0,"open":1403.4071,"prevYearClose":1284.7982,"prevWeekClose":1403.9366,"prevMonthClose":1502.9401,"prevQuarterClose":1502.9401,"fiveDayClose":1393.7178,"twentyDayClose":1452.8525,"sixtyDayClose":1279.2769,"secType":"PLATE","market":"US","turnoverRate":0.007862,"peRate":530.699707,"marketCap":157928380119.5,"floatMarketCap":157302737571.5,"timestamp":1745265599999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":2,"down":9,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526352377","title":"2 Top Dividend Stocks That Could Set You Up for Life","url":"https://stock-news.laohu8.com/highlight/detail?id=2526352377","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526352377?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:00","pubTimestamp":1744196400,"startTime":"0","endTime":"0","summary":"AbbVie and Gilead Sciences are leading drugmakers in immunology and HIV, respectively.When counting the time it spent under Abbott Laboratories, AbbVie has increased its payouts for 53 consecutive years. It's not like the drugmaker has been slacking off since 2013, either; its payouts have grown by 310% since its IPO. The stock offers a juicy forward yield of 3.5% and a reasonable cash payout ratio of just under 62%.AbbVie looks like a fantastic dividend stock to buy and hold for a long time.2. Gilead SciencesGilead Sciences is a leading biotech company that develops products across several therapeutic areas. The company is best known for its work in the HIV drug market, where it is arguably the leader. Last year, Gilead's Biktarvy -- the top-selling HIV regimen in the U.S. -- generated","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/09/2-top-dividend-stocks-that-could-set-you-up-for/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4504","LU1839511570.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0234572021.USD","BK4581","LU2237957902.USD","LU2133065610.SGD","LU2468319806.SGD","LU1023059063.AUD","LU0058720904.USD","BK4583","IE00BSNM7G36.USD","SG9999002224.SGD","SG9999002232.USD","BK4082","LU0289739699.SGD","IE00BFTCPJ56.SGD","BK4550","LU2237957811.SGD","SGXZ23171101.USD","LU1914381329.SGD","BK4585","IE0002141913.USD","LU0122379950.USD","LU2112291526.USD","LU1989763427.SGD","LU1066051498.USD","LU1721429741.USD","IE00BJJMRZ35.SGD","BK4533","LU0234570918.USD","LU1057294990.SGD","IE00B2B36J28.USD","ABT","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","LU0868494617.USD","LU0109394709.USD","LU1585245621.USD","BK4568","BK4592","IE0002270589.USD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588"],"gpt_icon":0},{"id":"2525819387","title":"Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2525819387","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525819387?lang=en_us&edition=fundamental","pubTime":"2025-04-08 22:28","pubTimestamp":1744122527,"startTime":"0","endTime":"0","summary":"Applied DNA Sciences  said Tuesday it regained compliance with Nasdaq's minimum bid price requirement.The company said it received a notice from Nasdaq on Monday, stating that Applied DNA Sciences' stock had a closing bid price of at least $1 for 16 consecutive business days through Friday.Shares of Applied DNA Sciences were up over 13% in recent Tuesday trading.Price: 1.47, Change: +0.17, Percent Change: +13.08","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4112","NDAQ","BK4585","APDN","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4583","BK4139","NQmain","LU2210150020.SGD","IE00B3QW5Z07.USD","LU2210149790.SGD","DNA","BK4109",".IXIC","LU2095319765.USD","IE00BKPKM429.USD","BK4121"],"gpt_icon":1},{"id":"2525158758","title":"Siga Technologies Shares Climb on Special Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2525158758","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525158758?lang=en_us&edition=fundamental","pubTime":"2025-04-08 22:04","pubTimestamp":1744121040,"startTime":"0","endTime":"0","summary":"Shares of Siga Technologies jumped after the company's board declared a 60-cent per-share special cash dividend.The stock was up 12% at $5.95 in early trading. Shares were changing hands at $9 this time a year ago.The New York pharmaceutical company said Tuesday that the dividend is payable on May 15 to shareholders of record as of April 29.This is the fourth year in a row that the company has issued a special cash dividend. Siga said the payout reflects the strength of its balance sheet and its confidence in the future of the business.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4007","SIGA"],"gpt_icon":0},{"id":"2525136328","title":"SIGA Technologies Declares Special Cash Dividend of $0.60 per Share, Payable May 15 to Holders as of April 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2525136328","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525136328?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:58","pubTimestamp":1744120715,"startTime":"0","endTime":"0","summary":"Price: 5.95, Change: +0.62, Percent Change: +11.63","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SIGA","BK4007","BK4583"],"gpt_icon":0},{"id":"2525705813","title":"Gilead Sciences: The Global Health Challenge of HIV and Hepatitis B Coinfections","url":"https://stock-news.laohu8.com/highlight/detail?id=2525705813","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525705813?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:40","pubTimestamp":1744119600,"startTime":"0","endTime":"0","summary":"NORTHAMPTON, MA / ACCESS Newswire / April 8, 2025 / In 2019, Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with hepatitis B  and with advanced HIV.\"Since both viruses are bloodborne and transmitted in similar ways, coinfections can be quite common,\" says Dr. Anchalee Avihingsanon, the lead clinical researcher at the Thai Red Cross AIDS and Infectious Diseases Research Centre where Somchai sought treatment.Anchalee is all too familiar with the prevalence and effect of coinfections as nearly 20% of the patients she sees are living with both HBV and HIV.\"We must acknowledge that HBV-HIV coinfection represents a major global public health challenge that increases morbidity and mortality beyond either infection alone,\" she says.HIV-HBV coinfection rates can reach 25% in areas where both viruses are endemic, such as in Asia. In some parts of Asia, HBV is endemic with a projected 70% of the population showing serologic ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-global-health-challenge-134000249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","BK4566","IE00B3T34201.USD","LU2087621335.USD","LU0289739699.SGD","BK4568","IE00B7SZLL34.SGD","BK4532","BK4578","BK4588","LU0320765992.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4585","LU0234570918.USD","BK4583","IE00BSNM7G36.USD","LU1430594728.SGD","IE0002270589.USD","LU1839511570.USD","LU1585245621.USD","LU2468319806.SGD","LU0889565916.HKD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2089984988.USD","GILD","BK4139","LU0058720904.USD","IE00B19Z3581.USD","LU1066053197.SGD","LU1066051498.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2525890852","title":"Applied DNA regains compliance with Nasdaq minimum bid price rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2525890852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525890852?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:10","pubTimestamp":1744117810,"startTime":"0","endTime":"0","summary":"Applied DNA Sciences (APDN) received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market, informing the Com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/applied-dna-regains-compliance-with-nasdaq-minimum-bid-price-rule?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/applied-dna-regains-compliance-with-nasdaq-minimum-bid-price-rule?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSYW.SI","BK4583","USJW.SI","USAW.SI","BK4112","IE00B64PRP62.GBP","NQmain","LU2095319765.USD",".IXIC","BK4121","DNA","TQQQ","BK4109","IE00BKPKM429.USD","QLD","IE00B3QW5Z07.USD","LU2210149790.SGD","NVIW.SI","BK4585","IE00BGHQF748.EUR","SQQQ","LU2210150020.SGD","QID","BK4139","MNQmain","APDN","BK4588","NDAQ","PSQ"],"gpt_icon":0},{"id":"2525281854","title":"Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2525281854","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525281854?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:00","pubTimestamp":1744117200,"startTime":"0","endTime":"0","summary":"STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc.  , a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market , informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550 .As previously reported, the Company was notified onNovember 12, 2024, that its common stock failed to maintain a minimum bid price of$1.00over the previous 30 consecutive business days as required by the Minimum Bid Price Requirement. To regain compliance with the Minimum Bid Price Requirement, the closing bid of the Company's common stockneeded to be at least$1.00for a minimum of 10 consecutive business days.Nasdaq determined that for 16 consecutive business days, from March 14 through April 4, 2025, the closing bid price of the Company's common stock was $1.00 per share or greater. Accordingl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/applied-dna-regains-compliance-nasdaq-130000412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","IE00B64PRP62.GBP","SQQQ","BK4121","BK4585","BK4112","TQQQ","BK4109","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","TSYW.SI","MNQmain","DNA","NVIW.SI","BK4588","NQmain","QID","LU2210150020.SGD","NDAQ","QLD","USAW.SI",".IXIC","LU2210149790.SGD","IE00B3QW5Z07.USD","PSQ","BK4583","APDN","BK4139"],"gpt_icon":1},{"id":"2525893045","title":"SIGA Declares Special Cash Dividend of $0.60 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2525893045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525893045?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:30","pubTimestamp":1744111800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUAC4DWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","SIGA","BK4007"],"gpt_icon":0},{"id":"2525895583","title":"Press Release: SIGA Declares Special Cash Dividend of $0.60 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2525895583","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525895583?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:30","pubTimestamp":1744111800,"startTime":"0","endTime":"0","summary":"NEW YORK, April 08, 2025  -- SIGA Technologies, Inc.  , a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company's common stock. This represents the fourth straight year of a special cash dividend. The amount of the dividend declared is consistent with the level of the dividend declared in March 2024. The dividend is payable on May 15, 2025, to shareholders of record at the close of business on April 29, 2025.\"Today's announcement of a special cash dividend reflects the strength of our balance sheet and continued confidence in the future of our business,\" said Diem Nguyen, Chief Executive Officer. \"As we look ahead, we remain committed to disciplined financial management and strategic execution to drive long-term shareholder value.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","BK4583","SIGA","BK4232","BK4007"],"gpt_icon":0},{"id":"2525045370","title":"Siga Technologies Inc. (SIGA) Declines More Than Market: Some Information for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2525045370","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525045370?lang=en_us&edition=fundamental","pubTime":"2025-04-08 05:50","pubTimestamp":1744062614,"startTime":"0","endTime":"0","summary":"Siga Technologies Inc.  closed at $5.32 in the latest trading session, marking a -1.3% move from the prior day. This change lagged the S&P 500's daily loss of 0.23%. Meanwhile, the Dow experienced a drop of 0.91%, and the technology-dominated Nasdaq saw an increase of 0.1%.Prior to today's trading, shares of the company had lost 5.27% over the past month. This has was narrower than the Medical sector's loss of 10.2% and the S&P 500's loss of 12.13% in that time.Investors will be eagerly watching for the performance of Siga Technologies Inc. in its upcoming earnings disclosure.Investors should also take note of any recent adjustments to analyst estimates for Siga Technologies Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Looking at valuation, Siga Technologies Inc. is presently trading at a Forward P/E ratio of 41.46. Its industry s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/siga-technologies-inc-siga-declines-215014479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","III","BK4007","ISBC","BK4583","BK4134","SIGA"],"gpt_icon":0},{"id":"2525207390","title":"5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525207390","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525207390?lang=en_us&edition=fundamental","pubTime":"2025-04-08 01:22","pubTimestamp":1744046520,"startTime":"0","endTime":"0","summary":"The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing geopolitical tension. While 2025 started on an encouraging note and strong quarterly results buoyed investor optimism, a likely overall slowdown does not bode well. Nonetheless, given the continuous need for innovative medical treatments, irrespective of the state of the economy, the dynamic biotech industry will continue to grab investors’ interest despite the inherent volatility and uncertain macroeconomic environment.M&A activity is likely to accelerate in 2025 under the Trump administration and expected deregulation. Pharma and biotech industry leaders consistently seek to expand their product portfolios and pipelines through strategic collaborations and acquisitions. While oncology and immuno-oncology companies have always been at the top of acquisition targets, the lucrative obesity sector and gene-editing space are in spotlight as of now.Biotech companies like Gilead","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/5-biotech-stocks-worth-adding-172200110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","IE00B3T34201.USD","OEF","BK4585","IE0002270589.USD","LU0889565916.HKD","LU1571399168.USD","BK4559","LU1839511570.USD","SDS","VOO","BK4588","OEX","SH","IE00BKVL7J92.USD","BMRN","BK4139","KRYS","BK4504","LU2065171311.SGD","BK4583","LU0058720904.USD","LU1066053197.SGD","BK4578","LU0320765992.SGD","ESmain","IVV","LU2065169927.USD","LU0234570918.USD","ADMA","SPY","LU2065171402.SGD","LU2468319806.SGD","BK4532","GILD","BK4550","LU2065170008.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2089984988.USD","LU0289739699.SGD","SSO","BK4581",".SPX","FOLD"],"gpt_icon":1},{"id":"2525468042","title":"Viatris to Pay Up to $335M in Opioid Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2525468042","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525468042?lang=en_us&edition=fundamental","pubTime":"2025-04-07 22:36","pubTimestamp":1744036560,"startTime":"0","endTime":"0","summary":"Viatris has agreed to pay as much as $335 million to settle claims regarding its sale of opioids.The Pittsburgh pharmaceutical company said Monday it was not admitting wrongdoing, but had agreed to settle with states, local governments and tribes that had brought lawsuits against it and several other drug companies. The claims related to the sale, marketing and distribution practices of prescription opioid products.Viatris has accrued about $270 million for the settlement, it said in its annual report filed in February. Its payment depends on its level of participation in the settlement. If it pays the highest amount, it will make annual payments over nine months of $27.5 million to $40 million each.The money is planned to go toward state and local efforts to address opioid-related issues, Viatris said.Shares fell 2.4% to $7.44 mid-morning Monday, and earlier hit a new 52-week low of $7.15.Viatris, along with other drug companies and pharmacies, is a defendant in more than 1,000 cases ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Viatris to Pay Up to $335M in Opioid Settlement","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","LU1839511570.USD","BK4585","BK4007","BK4588","VTRS","BK4583"],"gpt_icon":0},{"id":"2525505046","title":"Viatris Shares Down 4.7% as Co to Pay up to $335 Million to Resolve Opioid-Related Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2525505046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525505046?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:41","pubTimestamp":1744033299,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL0YV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","VTRS","BK4583","LU1839511570.USD","LU2087621335.USD","BK4007","BK4588"],"gpt_icon":0},{"id":"2525440043","title":"Wall Street Sinks Into Tariff Turmoil as US Equity Futures Drop Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2525440043","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525440043?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:07","pubTimestamp":1744031254,"startTime":"0","endTime":"0","summary":"US equity futures were falling ahead of Monday's opening bell, extending last week's losses fueled by President Donald Trump's tariff policy.The Dow Jones Industrial Average futures were down 1.8%, S&P 500 futures were 2.1% lower, and Nasdaq futures fell 2.2%.Last week, the White House imposed sweeping tariffs against various countries, including China, which responded with its retaliatory tariffs.Oil prices were lower, with front-month global benchmark North Sea Brent crude down 2.4% at $64.02 per barrel and US West Texas Intermediate crude 2.5% lower at $60.44 per barrel.In other world markets, Japan's Nikkei closed 7.8% lower, Hong Kong's Hang Seng ended 13% lower, and China's Shanghai Composite finished 7.3% lower. Meanwhile, the UK's FTSE 100 was down 4%, and Germany's DAX index was 4.5% lower in Europe's early afternoon session.In equities, shares of Viatris  were 2% higher pre-bell after the company said it agreed to settle opioid-related claims through a nationwide settlement f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DDM","BK4585","LU1839511570.USD","LU2087621335.USD","SQQQ","QID","BK4588","NVIW.SI","NQmain","USAW.SI","BK4520","SDOW","BK4583","DXD",".IXIC","BK4516","QLD","BK4007","TSYW.SI",".DJI","X","BK4006","MNQmain","USJW.SI","UDOW","BK4215","PSQ","TQQQ","DOG","DJX",".SPX","EQR","VTRS"],"gpt_icon":1},{"id":"2525017277","title":"BUZZ-Viatris resolves opioid-related claims for $335 mln; shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2525017277","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525017277?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:16","pubTimestamp":1744028197,"startTime":"0","endTime":"0","summary":"BUZZ-Viatris resolves opioid-related claims for $335 mln; shares rise** Shares of the drug maker Viatris VTRS.O rise about 2.6% to $7.82 premarket** Co says would pay up to $335 mln over nine years as","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nL3N3QL16L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4588","BK4583","BK4007","LU2087621335.USD","BK4585","VTRS"],"gpt_icon":0},{"id":"2525201414","title":"Viatris to pay up to $335 million to resolve opioid-related claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2525201414","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525201414?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:36","pubTimestamp":1744025772,"startTime":"0","endTime":"0","summary":"UPDATE 3-Viatris to pay up to $335 million to resolve opioid-related claimsAdds additional background in paragraphs 2-3 and 6-8, statement from New York Attorney General in paragraph 4. The company sells opioid products in the form of its painkiller Ultiva and the Fentanyl Transdermal System, which is a generic version of Johnson & Johnson's JNJ.N branded fentanyl patch product, Duragesic.Viatris is one of numerous drugmakers accused by state and local governments of downplaying opioid drugs' risks.The long-running opioid litigation, which also includes claims that distributors and pharmacies ignored red flags that drugs were being distributed illegally, has already resulted in more than $50 billion in settlements.Most recently, Purdue Pharma and its Sackler family owners in January reached a $7.4 billion settlement to resolve thousands of lawsuits over their pain medication OxyContin, which is widely blamed for helping spark the crisis.Opioid-related overdoses claimed more than 80,000","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nL3N3QL13G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","BK4583","LU2087621335.USD","BK4007","LU1839511570.USD","BK4585","BK4588"],"gpt_icon":1},{"id":"2525011737","title":"Viatris to Settle Opioid Claims Through Nationwide Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=2525011737","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525011737?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:22","pubTimestamp":1744024932,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) said Monday it plans to settle opioid-related claims against the company and some of its subsidiaries by states, local governments, and Tribes through a nationwide settlement framework.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2087621335.USD","BK4007","VTRS","BK4585","BK4588","BK4583","LU1839511570.USD"],"gpt_icon":0},{"id":"2525014338","title":"Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects","url":"https://stock-news.laohu8.com/highlight/detail?id=2525014338","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525014338?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:16","pubTimestamp":1744024560,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals (TNXP) presented data in a poster presentation at the AAPM 2025 Annual Meeting, held April 3-6, 2025, in Austin, Texas. “Desi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tonix-pharmaceuticals-presents-data-analyses-of-tnx-102-sl-effects-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tonix-pharmaceuticals-presents-data-analyses-of-tnx-102-sl-effects-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","TNXP","BK4139"],"gpt_icon":0},{"id":"2525829014","title":"Viatris reaches nationwide settlement to resolve opioid-related claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2525829014","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525829014?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:11","pubTimestamp":1744024319,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) has reached a nationwide settlement framework to resolve opioid-related claims by states, local governments, and Tribes against the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viatris-reaches-nationwide-settlement-to-resolve-opioid-related-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viatris-reaches-nationwide-settlement-to-resolve-opioid-related-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTRS","LU1839511570.USD","BK4588","BK4583","LU2087621335.USD","BK4007","BK4585"],"gpt_icon":0},{"id":"2525019000","title":"BRIEF-Viatris Statement On Nationwide Settlement To Resolve Opioid-Related Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2525019000","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525019000?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:05","pubTimestamp":1744023921,"startTime":"0","endTime":"0","summary":"BRIEF-Viatris Statement On Nationwide Settlement To Resolve Opioid-Related ClaimsApril 7 (Reuters) - Viatris Inc VTRS.O:VIATRIS STATEMENT ON NATIONWIDE SETTLEMENT TO RESOLVE OPIOID-RELATED CLAIMSVIATR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUAB3LHRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4583","BK4588","VTRS","LU1839511570.USD","BK4007","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":85,"code":"91000000","status":"200"}]}}